Results 131 to 140 of about 3,140 (170)

Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy. [PDF]

JCO Precis Oncol
Kreitman RJ, Schroeder B, Arons E, Yuan C, Wang HW, Raffeld M, Xi L, Pittaluga S, Zhou H, Gould M, Shpilman I, Turkbey E, Calvo KR, James L, Ortiz OS, Highfill S, Stroncek D, Yates B, Pastan I, Shah NN.   +19 more
europepmc   +1 more source

<i>Pastinaca sativa</i> L.: Nutritional Composition, Phytochemistry, and Pharmacological Properties Supporting Its Potential as a Functional Food and Therapeutic Agent. [PDF]

Food Sci Nutr
Khatua S, Nag A, Sen S, Sarkar J, Acharya K, Calina D, Setzer WN, Sharifi-Rad J.   +7 more
europepmc   +1 more source

Gender Disparity in Enrollment in Clinical Trials for Hairy Cell Leukemia Treatments in the Last 40 Years. [PDF]

EJHaem
Borja-Montes OF, Bode A, Escobar-Gil T, Toro-Pedroza A, Epperla N, Andritsos LA.   +5 more
europepmc   +1 more source

Transdifferentiation of Hairy Cell Leukemia to Lytic and Mass-Producing Histiocytic Sarcoma: A Novel Head and Neck Example and Review of the Literature. [PDF]

Head Neck Pathol
Davies AJ, Daneshpajouhnejad P, Patwardhan M, Xu Z, Cox DP.   +4 more
europepmc   +1 more source

Exploring the Vasculitis-Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications. [PDF]

Adv Sci (Weinh)
Shi X, Li Z, Ma X, Zhang B, Wu X, Fan H, Liu R, Jiang H, Chu CQ.   +8 more
europepmc   +1 more source

Targeted panel sequencing for refining B-cell lymphoma diagnosis: a real-life, reference center experience. [PDF]

Virchows Arch
Böck J, Maurus K, Doll J, Brändlein S, Yang Q, Kurz KS, Ott G, Anagnostopoulos I, Rosenwald A, Zamò A, Gerhard-Hartmann E.   +10 more
europepmc   +1 more source

Hairy Cell Leukemia With Splenic Rupture: Hematological Changes and Disappearance of Hairy Morphology After Splenectomy. [PDF]

J Hematol
Kim S, Mikami A, Stull W.
europepmc   +1 more source

Advancing the Diagnosis of Non-Hodgkin Lymphoma Through Next-Generation Sequencing in Developing Countries: An Evaluation of Progress-A Narrative Review. [PDF]

Health Sci Rep
Saeidnia M, Shokri M, Nourmohammadi H, Radmehr S, Babashahi M, Moradi M, Karimian M, Panji M, Motevaseli E.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Management of hairy cell leukemia variant

Leukemia and Lymphoma, 2011
Hairy cell leukemia variant (HCL-V) is now included in the World Health Organization (WHO) classification as a provisional entity and is no longer considered to be biologically related to classic HCL (HCL-C). The clinical course of HCL-V is variable but usually more aggressive, and the median survival of patients with HCL-V is significantly shorter ...
Tadeusz Robak
exaly   +3 more sources

Current treatment options in hairy cell leukemia and hairy cell leukemia variant

Cancer Treatment Reviews, 2006
Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by splenomegaly, pancytopenia and circulating lymphocytes displaying prominent cytoplasmic projections. HCL has usually an indolent course and the patients with asymptomatic disease do not require therapy. Treatment of progressive symptomatic HCL includes a variety
Tadeusz Robak
exaly   +3 more sources